Navigation Links
Life Sciences Discovery Fund announces $3.7m in research and development grants
Date:9/17/2013

SEATTLE, Washington, September 13, 2013 For-profit and non-profit organizations in Washington state will receive $1.25M in Proof of Concept grant funding to accelerate the translation of promising health-related technologies from concept to commercialization, the Life Sciences Discovery Fund (LSDF) announced today. Also announced was $2.4M in Opportunity grants for two major research and development initiatives. (See Backgrounder Information.)

The LSDF Board of Trustees made the final award selections following review of proposals for scientific and technical merit, potential impact on health and health care in Washington, and future economic and commercial returns to the state.

The five Proof of Concept grants will advance products to improve the prevention, diagnosis, or treatment of Alzheimer's disease, brain cancer, and tooth decay. Funding will also support technology to increase biomedical research productivity and enable development of safer drugs.

"This latest set of Proof of Concept awards is our final cohort for the 2012-2013 funding cycle, and we are thrilled to close this cycle on such a high note," said John DesRosier, LSDF executive director. "These grants will foster commercialization of novel technologies directed at specific diseases such as Alzheimer's, as well as at cutting-edge tools with the potential to enhance research and drug development for many diseases, in Washington and beyond."

The Opportunity grants to the Seattle Children's Research Institute (SCRI) and the University of Washington (UW) support initiatives that significantly leverage LSDF dollars against funds from other sources. Funding for both grants is contingent upon receipt of the leveraged commitments described in the proposals.

The SCRI award will fund critical studies of a cancer immunotherapy regimen that is in clinical trials in children and adults, in support of principal investigator Michael Jensen's vision to develop a leading immunotherapy program in Seattle. SCRI and partners will match the LSDF dollars through grants and philanthropic donations.

The UW award will support the launch of the Institute for Protein Design and the development and commercialization of medically useful proteins from the laboratory of principal investigator David Baker. LSDF funding will be matched by contributions from UW and private donors.

"These Opportunity grants, to two of our state's top research institutions, will help Washington maintain its leadership position in cancer research and treatment and capitalize upon the outputs of some of our most innovative and productive investigators," noted board chair Carol Dahl.


'/>"/>

Contact: Cathyryne Manner
manner@lsdfa.org
206-456-9583
Life Sciences Discovery Fund
Source:Eurekalert

Related medicine news :

1. UAS LifeSciences Launches New Brand at Expo East
2. New Name, Same Commitment to Advancing the Neurological Sciences: The Movement Disorder Society (MDS) Becomes the International Parkinson and Movement Disorder Society
3. Western University of Health Sciences to Welcome More Than 1,100 New Students
4. AxoGen, Inc. to Present at the Wedbush 2013 Life Sciences Management Access Conference
5. Patheon’s Michael Lehmann Named Among PharmaVOICE 100 List of Most Inspiring People in Life Sciences Industry
6. Scott Sheldon – Specialist in Healthcare and Life Sciences Supply Chain & Official Sponsor of LogiPharma 2013
7. Market Publishers Ltd and Select Biosciences Sign Partnership Agreement
8. CMUs Kathryn Roeder to receive Outstanding Achievement by a Woman in Statistical Sciences award
9. AKA Enterprise Solutions Launches CRM and ERP Web Site for Life Sciences
10. Lauren Sciences LLC awarded second Michael J. Fox Foundation grant to further develop V-Smart™ Therapeutic for Parkinsons disease
11. esyringe® Celebrates Expansion in Life Sciences Sector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology: